The DOI matches its Crossref record; 201 of the 201 references it cites were found in a registry or an index.
Transcriptional control of human p53-regulated genes
Abstract
The p53 protein regulates the transcription of many different genes in response to a wide variety of stress signals. Following DNA damage, p53 regulates key processes, including DNA repair, cell-cycle arrest, senescence and apoptosis, in order to suppress cancer. This Analysis article provides an overview of the current knowledge of p53-regulated genes in these pathways and others, and the mechanisms of their regulation. In addition, we present the most comprehensive list so far of human p53-regulated genes and their experimentally validated, functional binding sites that confer p53 regulation.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“The tumor suppressor p53 functions primarily as a transcription factor.”
From Census and evaluation of p53 target genes (2017) · cites this paper as [5]
In the citing paper
“The prevailing function of the p53 tumor suppressor is the transcriptional control of target genes that regulate numerous cellular processes, including cell cycle and apoptosis.5, 6”
From Census and evaluation of p53 target genes (2017) · cites this paper as [5]
In the citing paper
“p53 is an crucial tumor suppressor that is mutated in more than 50% of human cancers”
From USP10 Regulates p53 Localization and Stability by Deubiquitinating p53 (2010) · cites this paper as Riley et al., 2008
Citations
Cites
p53, the cellular gatekeeper for growth and division
Levine, A. J. (1997) · Cell · doi:10.1016/s0092-8674(00)81871-1 · Cited by 7,693
Self-citationVogelstein, B., Lane, D., & Levine, A. J. (2000) · Nature · doi:10.1038/35042675 · Cited by 6,607 · cited 1×
“These include several types of DNA damage: telomere shortening, hypoxia, mitotic spindle damage, heat or cold shock, unfolded proteins, improper ribosomal biogenesis, nutritional deprivation in a transformed cell, and even the activation of some oncogenes by mutatio”
BackgroundSelf-citationEddy, S. R. (1998) · Bioinformatics · doi:10.1093/bioinformatics/14.9.755 · Cited by 5,515
Sequence logos: a new way to display consensus sequences
Schneider, T. D., & Stephens, R. M. (1990) · Nucleic Acids Research · doi:10.1093/nar/18.20.6097 · Cited by 3,354
Durbin, R. M., Eddy, S. R., Krogh, A., & Mitchison, G. (1998) · Cambridge University Press eBooks · doi:10.1017/cbo9780511790492 · Cited by 3,255
Activation of p53 Sequence-Specific DNA Binding by Acetylation of the p53 C-Terminal Domain
Gu, W., & Roeder, R. G. (1997) · Cell · doi:10.1016/s0092-8674(00)80521-8 · Cited by 2,559
Crystal Structure of a p53 Tumor Suppressor-DNA Complex: Understanding Tumorigenic Mutations
Cho, Y., Gorina, S., Jeffrey, P. D., & Pavletich, N. P. (1994) · Science · doi:10.1126/science.8023157 · Cited by 2,559 · cited 1×
“On the basis of X-ray crystallography studies of the p53 DNA-binding core domain bound to a p53-RE DNA sequence, the most important bases for interactions with the p53 protein are the central RCWWGY, which come into close contact with the amino acids from the p53 core domai”
BackgroundHistone deacetylase inhibitors and the promise of epigenetic (and more) treatments for cancer
Minucci, S., & Pelicci, P. G. (2006) · Nature reviews. Cancer · doi:10.1038/nrc1779 · Cited by 2,234
Wild-type p53 induces apoptosis of myeloid leukaemic cells that is inhibited by interleukin-6
Yonish-Rouach, E., Resnftzky, D., Lotem, J., Sachs, L., Kimchi, A., & Oren, M. (1991) · Nature · doi:10.1038/352345a0 · Cited by 2,079
Maximum Entropy Modeling of Short Sequence Motifs with Applications to RNA Splicing Signals
Yeo, G. W.-M., & Burge, C. B. (2004) · Journal of Computational Biology · doi:10.1089/1066527041410418 · Cited by 2,042
Flagged first, then by citations
Cited by
Sorted by citations
Items 301–400 of 1,000
Agarwal, S., Bell, C. M., Rothbart, S. B., & Moran, R. G. (2015) · Journal of Biological Chemistry · doi:10.1074/jbc.m115.665133 · Cited by 97
Janssens, V., & Rebollo, A. (2012) · Current Molecular Medicine · doi:10.2174/156652412799218930 · Cited by 95
Detect accessible chromatin using ATAC-sequencing, from principle to applications
Sun, Y., Miao, N., & Sun, T. (2019) · Hereditas · doi:10.1186/s41065-019-0105-9 · Cited by 92
Seitz, S., Schleithoff, E. S., Koch, A., Schuster, A., Teufel, A., Staib, F., Stremmel, W., Melino, G., Krammer, P. H., Schilling, T., et al. (2009) · International Journal of Cancer · doi:10.1002/ijc.24861 · Cited by 96
Ching, B., Chen, X. L., Yong, J. H. A., Wilson, J. M., Hiong, K. C., Sim, E. W. L., Wong, W. P., Lam, S. H., Chew, S. F., & Ip, Y. K. (2013) · Frontiers in Physiology · doi:10.3389/fphys.2013.00135 · Cited by 93
Jin, J.-Z., Lin, G., Huang, H., Xu, D. M., Yu, H., Ma, X., Zhu, L., Ma, D., & Jiang, H. (2014) · International Journal of Biological Sciences · doi:10.7150/ijbs.7730 · Cited by 96
Sullivan, K. D., Gallant‐Behm, C. L., Henry, R. E., Fraikin, J.-L., & Espinosa, J. M. (2012) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2012.01.004 · Cited by 96
Reconciling binding mechanisms of intrinsically disordered proteins
Espinoza-Fonseca, M. (2009) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2009.02.151 · Cited by 98
Porter, J. R., Fisher, B. E., & Batchelor, E. (2016) · Cell Systems · doi:10.1016/j.cels.2016.03.006 · Cited by 90
Wink, S., Hiemstra, S. W., Huppelschoten, S., Danen, E. H. J., Niemeijer, M., Hendriks, G., Vrieling, H., Herpers, B., & van de Water, B. (2014) · Chemical Research in Toxicology · doi:10.1021/tx4004038 · Cited by 93
Li, L., Li, L., Li, W., Chen, T., Zou, B., Zhao, L., Wang, H., Wang, X., Xu, L., Liu, X., et al. (2018) · Nature Communications · doi:10.1038/s41467-018-07127-8 · Cited by 90
TP53 mutations in cancer: Molecular features and therapeutic opportunities (Review)
Tornesello, M. L. (2024) · International Journal of Molecular Medicine · doi:10.3892/ijmm.2024.5448 · Cited by 105
Pani, G., Koch, O. R., & Galeotti, T. (2008) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2008.10.011 · Cited by 91
p53 binds preferentially to genomic regions with high DNA-encoded nucleosome occupancyPreprint
Nili, E. L., Field, Y., Lubling, Y., Widom, J., Oren, M., & Segal, E. (2010) · Genome Research · doi:10.1101/gr.103945.109 · Cited by 92
The human papillomavirus E7 oncoprotein as a regulator of transcription
Songock, W. K., Kim, S., & Bodily, J. M. (2016) · Virus Research · doi:10.1016/j.virusres.2016.10.017 · Cited by 97
Elsayed, A. M., Sherif, N. M., Hassan, N. S., Althobaiti, F., Hanafy, N. A. N., & Sahyon, H. A. E. (2021) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2021.06.085 · Cited by 93
p53 transcriptionally regulates SQLE to repress cholesterol synthesis and tumor growth
Sun, H., Li, L., Li, W., Yang, F., Zhang, Z., Liu, Z., & Du, W. (2021) · EMBO Reports · doi:10.15252/embr.202152537 · Cited by 90
Targeting the DNA damage response for cancer therapy
Powell, S. N., & Bindra, R. S. (2009) · DNA repair · doi:10.1016/j.dnarep.2009.04.011 · Cited by 86
King, S., Purdie, C. A., Bray, S. E., Quinlan, P., Jordan, L. B., Thompson, A. M., & Meek, D. W. (2012) · Breast Cancer Research · doi:10.1186/bcr3136 · Cited by 88
In vivo analysis of p53 tumor suppressor function using genetically engineered mouse models
Brož, D. K., & Attardi, L. D. (2010) · Carcinogenesis · doi:10.1093/carcin/bgp331 · Cited by 92
p53-Independent Apoptosis Limits DNA Damage-Induced Aneuploidy
McNamee, L. M., & Brodsky, M. H. (2009) · Genetics · doi:10.1534/genetics.109.102327 · Cited by 89
Obacz, J., Pastoreková, S., Vojtesek, B., & Hrstka, R. (2013) · Molecular Cancer · doi:10.1186/1476-4598-12-93 · Cited by 92
Long noncoding RNAs in the p53 network
Chaudhary, R., & Lal, A. (2016) · Wiley Interdisciplinary Reviews - RNA · doi:10.1002/wrna.1410 · Cited by 88
Schlereth, K., Heyl, C., Krampitz, A.-M., Mernberger, M., Finkernagel, F., Scharfe, M., Jarek, M., Leich, E., Rosenwald, A., & Stiewe, T. (2013) · PLoS Genetics · doi:10.1371/journal.pgen.1003726 · Cited by 87
Flanagan, J. M., Funes, J. M., Henderson, S. R., Wild, L., Carey, N., & Boshoff, C. (2009) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-08-0636 · Cited by 87
Vascular aging: Molecular mechanisms and potential treatments for vascular rejuvenation
Mistriotis, P., & Andreadis, S. T. (2017) · Ageing Research Reviews · doi:10.1016/j.arr.2017.05.006 · Cited by 89
Liu, T., Ma, X., Ouyang, T., Chen, H., Lin, J., Liu, J., Xiao, Y., Yu, J., & Huang, Y. (2018) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2018.05.174 · Cited by 88
Jeay, S., Ferretti, S., Holzer, P., Fuchs, J., Chapeau, E. A., Wartmann, M., Sterker, D., Romanet, V., Murakami, M., Kerr, G., et al. (2018) · Cancer Research · doi:10.1158/0008-5472.can-18-0338 · Cited by 87
Reciprocal repression between TUSC7 and miR-23b in gastric cancer
Qi, P., Xu, M., Shen, X.-H., Ni, S., Huang, D., Tan, C., Weng, W., Sheng, W.-Q., Zhou, X.-Y., & Du, X. (2015) · International Journal of Cancer · doi:10.1002/ijc.29516 · Cited by 87
Williams, K., Christensen, J. F., Rappsilber, J., Nielsen, A. L., Johansen, J. V., & Helin, K. (2014) · PLoS ONE · doi:10.1371/journal.pone.0096545 · Cited by 91
TGF-β induces p53/Smads complex formation in the PAI-1 promoter to activate transcription
Kawarada, Y., Inoue, Y., Kawasaki, F., Fukuura, K., Sato, K., Tanaka, T., Itoh, Y., & Hayashi, H. (2016) · Scientific Reports · doi:10.1038/srep35483 · Cited by 88
The critical molecular interconnections in regulating apoptosis and autophagy
Zhao, G., Pan, H., Ouyang, D.-Y., & He, X. (2015) · Annals of Medicine · doi:10.3109/07853890.2015.1040831 · Cited by 87
A systematic RNAi synthetic interaction screen reveals a link between p53 and snoRNP assembly
Krastev, D. B., Slabicki, M. M., Paszkowski‐Rogacz, M., Hubner, N. C., Junqueira, M., Shevchenko, A., Mann, M., Neugebauer, K. M., & Buchholz, F. (2011) · Nature Cell Biology · doi:10.1038/ncb2264 · Cited by 88
Platinum Complexes in Colorectal Cancer and Other Solid Tumors
Köberle, B., & Schoch, S. (2021) · Cancers · doi:10.3390/cancers13092073 · Cited by 88
Chaudhary, R., Gryder, B. E., Woods, W. S., Subramanian, M., Jones, M. F., Li, X. L., Jenkins, L. M. M., Shabalina, S. A., Mo, M., Dasso, M., et al. (2017) · eLife · doi:10.7554/elife.23244 · Cited by 86
Misiewicz-Krzemińska, I., Sarasquete, M. E., Quwaider, D., Krzemiński, P., Ticona, F. V., Paíno, T., Delgado, M., Aires, A., Ocio, E. M., García‐Sánz, R., et al. (2012) · Haematologica · doi:10.3324/haematol.2012.070011 · Cited by 85
Inflammation and the chemical carcinogen benzo[a]pyrene: Partners in crime
Shi, Q., Godschalk, R., & van Schooten, F. (2017) · Mutation Research/Reviews in Mutation Research · doi:10.1016/j.mrrev.2017.08.003 · Cited by 88
Schmidt, K., Carroll, J. S., Yee, E., Thomas, D. D., Wert-Lamas, L., Neier, S. C., Sheynkman, G., Ritz, J., & Novina, C. D. (2019) · Cell Reports · doi:10.1016/j.celrep.2019.04.101 · Cited by 85
Zhao, T., Sun, D., Zhao, M., Lai, Y., Liu, Y., & Zhang, Z. (2020) · Environmental Pollution · doi:10.1016/j.envpol.2019.113908 · Cited by 85
Effects of TP53 mutational status on gene expression patterns across 10 human cancer types
Parikh, N., Hilsenbeck, S. G., Creighton, C. J., Dayaram, T., Shuck, R. L., Shinbrot, E., Liu, X., Gibbs, R. A., Wheeler, D. A., & Donehower, L. A. (2013) · The Journal of Pathology · doi:10.1002/path.4321 · Cited by 91
Solozobova, V. (2011) · World Journal of Biological Chemistry · doi:10.4331/wjbc.v2.i9.202 · Cited by 87
Towards an understanding of the role of p53 in adrenocortical carcinogenesis
Wasserman, J. D., Zambetti, G. P., & Malkin, D. (2012) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2011.09.010 · Cited by 84
Axin determines cell fate by controlling the p53 activation threshold after DNA damage
Li, Q., Lin, S., Wang, X., Lian, G., Lu, Z., Guo, H., Ruan, K., Wang, Y., Ye, Z., Han, J., et al. (2009) · Nature Cell Biology · doi:10.1038/ncb1927 · Cited by 84
Impact of Alu repeats on the evolution of human p53 binding sites
Cui, F., Sirotin, M. V., & Zhurkin, V. B. (2011) · Biology Direct · doi:10.1186/1745-6150-6-2 · Cited by 85
B-MYB Is Required for Recovery from the DNA Damage–Induced G2 Checkpoint in p53 Mutant Cells
Mannefeld, M., Klassen, E., & Gaubatz, S. (2009) · Cancer Research · doi:10.1158/0008-5472.can-08-4156 · Cited by 82
PHF2 histone demethylase acts as a tumor suppressor in association with p53 in cancer
Lee, K.-H., Park, J.-W., Sung, H.-S., Choi, Y.-J., Kim, W., Lee, H. S., Chung, H.-J., Shin, H.-W., Cho, C.-H., Kim, T.-Y., et al. (2014) · Oncogene · doi:10.1038/onc.2014.219 · Cited by 89
Distinct p53 genomic binding patterns in normal and cancer-derived human cells
Botcheva, K., McCorkle, S., McCombie, W. R., Dunn, J. J., & Anderson, C. W. (2011) · Cell Cycle · doi:10.4161/cc.10.24.18383 · Cited by 84
Laptenko, O., Tong, D. R., Manfredi, J. J., & Prives, C. L. (2016) · Trends in Biochemical Sciences · doi:10.1016/j.tibs.2016.08.011 · Cited by 88
Moulder, D. E., Hatoum, D., Tay, E. S. E., Lin, Y., & McGowan, E. M. (2018) · Cancers · doi:10.3390/cancers10060189 · Cited by 87
Khan, M. R., Xiang, S., Song, Z., & Wu, M. (2017) · The EMBO Journal · doi:10.15252/embj.201696239 · Cited by 82
Liu, Y., Pei, Z., Pan, T., Wang, H., Chen, W., & Lu, W. (2023) · Microbiological Research · doi:10.1016/j.micres.2023.127392 · Cited by 88
Wild-type p53 in cancer cells: When a guardian turns into a blackguard
Kim, E. L., Giese, A., & Deppert, W. (2008) · Biochemical Pharmacology · doi:10.1016/j.bcp.2008.08.030 · Cited by 83
Choubey, D., & Panchanathan, R. (2016) · Ageing Research Reviews · doi:10.1016/j.arr.2016.04.002 · Cited by 83
Therapeutic targeting of p53 by small molecules
Selivanova, G. (2010) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2010.02.006 · Cited by 84
Androgen induces G3BP2 and SUMO-mediated p53 nuclear export in prostate cancer
Ashikari, D., Takayama, K., Tanaka, T., Suzuki, Y., Obinata, D., Fujimura, T., Urano, T., Takahashi, S., & Inoue, S. (2017) · Oncogene · doi:10.1038/onc.2017.225 · Cited by 80
Small cell lung cancer: Subtypes and therapeutic implications
Wang, W., Shulman, A., Amann, J. M., Carbone, D. P., & Tsichlis, P. N. (2022) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2022.04.001 · Cited by 83
Chen, Y., Zhang, X., Machado, A. C. D., Ding, Y. C., Chen, Z., Qin, P. Z., Rohs, R., & Chen, L. (2013) · Nucleic Acids Research · doi:10.1093/nar/gkt584 · Cited by 85
Caspase Induction and BCL2 Inhibition in Human Adipose Tissue
Tinahones, F. J., Coín‐Aragüez, L., Murri, M., Oliva‐Olivera, W., Torres, M. D. M., Barbarroja, N., Gómez‐Huelgas, R., Malagón, M. M., & Bekay, R. E. (2012) · Diabetes Care · doi:10.2337/dc12-0194 · Cited by 83
Kinpara, S., Kijiyama, M., Takamori, A., Hasegawa, A., Sasada, A., Masuda, T., Tanaka, Y., Utsunomiya, A., & Kannagi, M. (2013) · Retrovirology · doi:10.1186/1742-4690-10-52 · Cited by 86
Reviving the guardian of the genome: Small molecule activators of p53
Nguyen, D., Liao, W., Zeng, S. X., & Lu, H. (2017) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2017.03.013 · Cited by 84
TRIM25 has a dual function in the p53/Mdm2 circuit
Zhang, P., Elabd, S., Hammer, S., Solozobova, V., Yan, H., Bartel, F., Inoue, S., Henrich, T., Wittbrodt, J., Loosli, F., et al. (2015) · Oncogene · doi:10.1038/onc.2015.21 · Cited by 79
Expanding the p53 regulatory network: LncRNAs take up the challenge
Grossi, E., Sánchez, Y., & Huarte, M. (2016) · Biochimica et Biophysica Acta (BBA) - Gene Regulatory Mechanisms · doi:10.1016/j.bbagrm.2015.07.011 · Cited by 78
Wang, Y. V., Leblanc, M., Wade, M., Jochemsen, A. G., & Wahl, G. M. (2009) · Cancer Cell · doi:10.1016/j.ccr.2009.05.008 · Cited by 79
p53 deficiency induces MTHFD2 transcription to promote cell proliferation and restrain DNA damage
Li, G. L., Wu, J., Li, L., & Jiang, P. (2021) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2019822118 · Cited by 79
Key role of ATF3 in p53-dependent DR5 induction upon DNA damage of human colon cancer cells
Taketani, K., Kawauchi, J., Tanaka, M., Ishizaki, H., Tanaka, Y., Sakai, T., Miyoshi, J., Maehara, Y., & Kitajima, S. (2011) · Oncogene · doi:10.1038/onc.2011.397 · Cited by 81
Yu, H., McDaid, R., Lee, J., Possik, P. A., Li, L., Kumar, S. M., Elder, D. E., Belle, P. A. V., Gimotty, P. A., Guerra, M., et al. (2009) · American Journal Of Pathology · doi:10.2353/ajpath.2009.081057 · Cited by 85
The Paradox of p53: What, How, and Why?Preprint
Aylon, Y., & Oren, M. (2016) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a026328 · Cited by 81
Scission of the p53-MDM2 Loop by Ribosomal Proteins
Zhou, X. Y., Liao, J.-M., Liao, W.-J., & Lu, H. (2012) · Genes & Cancer · doi:10.1177/1947601912455200 · Cited by 82
Porter, J. R., Fisher, B. E., Baranello, L., Liu, J. C., Kambach, D. M., Nie, Z., Koh, W. S., Luo, J., Stommel, J. M., Levens, D., et al. (2017) · Molecular Cell · doi:10.1016/j.molcel.2017.07.028 · Cited by 79
Histone demethylase JMJD5 is essential for embryonic development
Oh, S., & Janknecht, R. (2012) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2012.02.115 · Cited by 78
Polo-like kinases mediate cell survival in mitochondrial dysfunction
Matsumoto, T., Wang, P., Ma, W., Sung, H. J., Matoba, S., & Hwang, P. M. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0904229106 · Cited by 75
Tumor suppressor p53: from engaging DNA to target gene regulation
Sammons, M. A., Nguyen, T., McDade, S. S., & Fischer, M. (2020) · Nucleic Acids Research · doi:10.1093/nar/gkaa666 · Cited by 78
Plk2 promotes tumor growth and inhibits apoptosis by targeting Fbxw7/Cyclin E in colorectal cancer
Ou, B., Zhao, J., Guan, S., Wangpu, X., Zhu, C., Zong, Y., Ma, J., Sun, J. P., Zheng, M., Feng, H., et al. (2016) · Cancer Letters · doi:10.1016/j.canlet.2016.07.004 · Cited by 76
Computational analysis of auxin responsive elements in the Arabidopsis thaliana L. genome
Mironova, V., Omelyanchuk, N. A., Wiebe, D. S., & Levitsky, V. G. (2014) · BMC Genomics · doi:10.1186/1471-2164-15-s12-s4 · Cited by 77
Conservation of DNA-binding specificity and oligomerisation properties within the p53 family
Brandt, T., Petrovich, M., Joerger, A. C., & Veprintsev, D. B. (2009) · BMC Genomics · doi:10.1186/1471-2164-10-628 · Cited by 77
Oscillations of the p53-Akt Network: Implications on Cell Survival and Death
Wee, K. B., Surana, U., & Aguda, B. D. (2009) · PLoS ONE · doi:10.1371/journal.pone.0004407 · Cited by 77
Dai, F., Chen, Y., Song, Y., Huang, L., Zhai, D., Dong, Y., Lai, L., Zhang, T., Li, D., Pang, X., et al. (2012) · PLoS ONE · doi:10.1371/journal.pone.0052162 · Cited by 77
DNA Damage-Induced RORα Is Crucial for p53 Stabilization and Increased Apoptosis
Kim, H.-K., Lee, J. M., Lee, G., Bhin, J., Oh, S. K., Kim, K., Pyo, K. E., Lee, J. S., Yim, H. Y., Kim, K. I., et al. (2011) · Molecular Cell · doi:10.1016/j.molcel.2011.09.023 · Cited by 77
Meek, D. W., & Hupp, T. R. (2010) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2009.10.005 · Cited by 76
Dishevelled has a YAP nuclear export function in a tumor suppressor context-dependent manner
Lee, Y., Kim, N. H., Cho, E. S., Yang, J. H., Cha, Y. H., Kang, H. E., Yun, J. S., Cho, S. B., Lee, S.-H., Paclíková, P., et al. (2018) · Nature Communications · doi:10.1038/s41467-018-04757-w · Cited by 74
Mutant TP53 Posttranslational Modifications: Challenges and Opportunities
Nguyen, T., Menéndez, D., Resnick, M. A., & Anderson, C. W. (2014) · Human Mutation · doi:10.1002/humu.22506 · Cited by 77
Croft, D. R., Crighton, D., Samuel, M. S., Lourenço, F. C., Munro, J., Wood, J. M., Bensaad, K., Vousden, K. H., Sansom, O. J., Ryan, K. M., et al. (2010) · Cell Research · doi:10.1038/cr.2010.154 · Cited by 78
Shahid, A., Ali, R., Ali, N., Hasan, S. K., Bernwal, P., Afzal, S. M., Vafa, A., & Sultana, S. (2016) · Food and Chemical Toxicology · doi:10.1016/j.fct.2016.03.021 · Cited by 76
p53 regulates enhancer accessibility and activity in response to DNA damage
Younger, S. T., & Rinn, J. L. (2017) · Nucleic Acids Research · doi:10.1093/nar/gkx577 · Cited by 73
Regulation of Tumor Suppressor p53 and HCT116 Cell Physiology by Histone Demethylase JMJD2D/KDM4D
Kim, T., Oh, S., Shin, S., & Janknecht, R. (2012) · PLoS ONE · doi:10.1371/journal.pone.0034618 · Cited by 74
Galluzzi, L., Morselli, E., Kepp, O., Vitale, I., Pinti, M., & Kroemer, G. (2010) · Antioxidants and Redox Signaling · doi:10.1089/ars.2010.3504 · Cited by 83
Khan, R., Khan, A. Q., Qamar, W., Lateef, A., Ali, F. D. R., Rehman, M. U., Tahir, M., Sharma, S., & Sultana, S. (2012) · British Journal Of Nutrition · doi:10.1017/s0007114511007239 · Cited by 74
Jumonji histone demethylases as emerging therapeutic targets
Park, S. Y., Park, J., & Chun, Y. (2016) · Pharmacological Research · doi:10.1016/j.phrs.2016.01.026 · Cited by 75
ATM regulation of IL-8 links oxidative stress to cancer cell migration and invasion
Chen, W.-T., Ebelt, N. D., Stracker, T. H., Xhemalce, B., Van Den Berg, C. L., & Miller, K. M. (2015) · eLife · doi:10.7554/elife.07270 · Cited by 73
“Given the role of mutant p53 in transcriptional regulation, we hypothesized that ATM could similarly regulate the expression of genes involved in cell migration (Riley et al., 2008; Shiloh and Ziv, 2013).”
BackgroundStem cells: balancing resistance and sensitivity to DNA damage
Liu, J. C., Lerou, P. H., & Lahav, G. (2014) · Trends in Cell Biology · doi:10.1016/j.tcb.2014.03.002 · Cited by 74
TRIM8 modulates p53 activity to dictate cell cycle arrest
Caratozzolo, M. F., Micale, L., Turturo, M. G., Cornacchia, S., Fusco, C., Marzano, F., Augello, B., D’Erchia, A. M., Guerrini, L., Pesole, G., et al. (2012) · Cell Cycle · doi:10.4161/cc.11.3.19008 · Cited by 72
Liang, M., Yao, G., Yin, M., Lü, M., Tian, H., Liu, L., Lian, J., Huang, X., & Sun, F. (2013) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2013.02.014 · Cited by 74
Katoh (2009) · International Journal of Oncology · doi:10.3892/ijo_00000514 · Cited by 76
Whole-genome cartography of p53 response elements ranked on transactivation potential
Tebaldi, T., Zaccara, S., Alessandrini, F., Bisio, A., Ciribilli, Y., & Inga, A. (2015) · BMC Genomics · doi:10.1186/s12864-015-1643-9 · Cited by 72
TP53 Mutations in Human Cancer: Database Reassessment and Prospects for the Next Decade
Soussi, T. (2011) · Advances in cancer research · doi:10.1016/b978-0-12-386469-7.00005-0 · Cited by 77
Shankar, E., Zhang, A., Franco, D., & Gupta, S. (2017) · Molecules · doi:10.3390/molecules22020264 · Cited by 73
Chen, H., Yuan, Y., Zhang, C., Luo, A., Ding, F., Ma, J., Yang, S., Tian, Y., Tong, T., Zhan, Q., et al. (2012) · Journal of Biological Chemistry · doi:10.1074/jbc.m111.326975 · Cited by 73
Ellinger-Ziegelbauer, H. C., Fostel, J. M., Aruga, C., Bauer, D., Boitier, E., Deng, S., Dickinson, D. A., Fevre, A.-C. L., Fornace, A. J., Grenet, O., et al. (2009) · Toxicological Sciences · doi:10.1093/toxsci/kfp103 · Cited by 73
High and Low LET Radiation Differentially Induce Normal Tissue Damage Signals
Niemantsverdriet, M., van Goethem, M., Bron, R., Hogewerf, W., Brandenburg, S., Langendijk, J. A., van Luijk, P., & Coppes, R. P. (2012) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/j.ijrobp.2011.09.057 · Cited by 77
A Comprehensive and High-Resolution Genome-wide Response of p53 to Stress
Chang, G. S., Chen, X. A., Park, B., Rhee, H. S., Li, P., Han, K. H., Mishra, T., Chan-Salis, K. Y., Li, Y., Hardison, R. C., et al. (2014) · Cell Reports · doi:10.1016/j.celrep.2014.06.030 · Cited by 73
Metadata
- Authors
- Riley, T., Sontag, E., Chen, P., & Levine, A.
- Affiliations
- Institute for Advanced Study (US)
- Rutgers, The State University of New Jersey (US)
- Corresponding author
- Riley, Todd
- Venue
- Nature Reviews Molecular Cell Biology
- Published
- 2008-05
- Volume
- 9
- Issue
- 5
- Pages
- 402-412
- ISSN
- 1471-0072 (ISSN-L)
- 1471-0080
- OpenAlex
- W1964719993
- Cited by
- 1,921
- References
- 201
- Citations by year
- 2026: 36 · 2025: 45 · 2024: 56 · 2023: 73 · 2022: 85 · 2021: 97 · 2020: 79 · 2019: 92 · 2018: 110 · 2017: 134 · 2016: 131 · 2015: 115 · 2014: 154 · 2013: 143 · 2012: 153
- FWCI
- 12.97
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature Reviews Molecular Cell Biology (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Oncology › Cancer-related Molecular Pathways
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Genomics and Chromatin Dynamics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › DNA Repair Mechanisms
- Keywords
- p53, transcriptional regulation, p53 target genes, DNA damage response, DNA repair, cell cycle arrest, senescence, apoptosis, tumor suppression, transcription factor binding sites, stress signaling
- MeSH terms
- Base Sequence, Binding Sites, Cell Transformation, Neoplastic, DNA Damage, Gene Expression Regulation, Humans, Markov Chains, Molecular Sequence Data, Regulatory Sequences, Nucleic Acid, Transcription, Genetic, Signal Transduction, Genes, p53, Tumor Suppressor Protein p53, Response Elements, Regulatory Elements, Transcriptional
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review